Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) insider Sanjay Nayak sold 2,274 shares of Ocular Therapeutix stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $5.84, for a total value of $13,280.16. Following the sale, the insider now directly owns 178,026 shares of the company’s stock, […]
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Curtains for Rs 3,300-crore SPECS scheme; new PLI after polls financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
11.03.2024 - Leadership Appointments Move Ocular Towards Being a Leader in Retinal Care Screening Underway in AXPAXLI Phase 3 SOL-1 Trial for Wet AMD Topline Clinical Data for AXPAXLI in Diabetic Retinopathy and PAXTRAVA in Glaucoma Expected in Q2 2024 Cash .
Ocular Therapeutix™ Reports Fourth Quarter And Full Year 2023 Results menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.